Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study.
Lv J, Xu LX, Li ZX, Lin L, Wu CF, Quan TQ, Zhen ZC, Li WF, Tang LL, Mao YP, Chen L, Guo R, Zhang LL, Ai XL, Wu SY, Hao MY, Wei D, Li JB, Ma J, Chen YP, Zhou GQ, Sun Y.
Lv J, et al. Among authors: sun y.
Cancer Cell. 2024 Aug 12;42(8):1401-1414.e4. doi: 10.1016/j.ccell.2024.07.001. Epub 2024 Jul 25.
Cancer Cell. 2024.
PMID: 39059389
Free article.